Publications

Californian Consumer Attitudes on Accessing PrEP/PEP without a Prescription via a Community Pharmacy

The California Legislature passed Senate Bill 159 (SB159) in 2019 allowing pharmacists to initiate and furnish HIV pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) to eligible patients without a prescription. The law goes into effect on July 1, 2020. This report presents a preliminary summary of the attitudes and recommendations among potential consumers of PrEP/PEP without a prescription via a community pharmacy. 

Interventions to Combat the Infectious Disease Ramifications of the U.S. Opioid Crisis

In the second of a two-part series, we explore the impact of the opioid epidemic on HIV and other health conditions in California and Nevada. Downstream consequences of the U.S. opioid epidemic, including the many lives left in its wake, are a reminder that efforts to combat infectious disease must begin with the search for root causes and potential structural interventions. A syndemics approach facilitates research, policy, and practice that favors the understanding that this current crisis is not a problem associated with a single disease. For people who inject drugs, vulnerability for acquiring HIV and HCV are important considerations ... [Read More];

COVID-19 Organizational Health Survey

In May 2020, the California HIV/AIDS Policy Research Centers conducted an online survey to document the direct impact of COVID-19 on healthcare and social services providers working to address HIV, hepatitis C (HCV) and sexually transmitted diseases (STDs). Survey respondents included 70 organizations that submitted complete surveys. In response to the COVID-19 physical distancing measures placed both locally and statewide, respondents reporting shifting operations to maintain safety while continuing to serve their communities. We developed an infographic summarizing the impact of COVID-19 on healthcare and social services organizations in California, as well as the shifts in operations they have had ... [Read More];

PrEP Today and Tomorrow: On-Demand, Injections and Topicals

Given the low uptake of daily oral PrEP, exploration of safe alternative agents (e.g. medications) and alternative modalities to deliver PrEP (e.g. alternative dosing, injectables, topical agents, and long-acting treatment) are integral to address PrEP disparities moving forward. The purpose of this brief is to provide an overview of existing and future PrEP agents and modalities.

Documenting best practices for maintaining access to HIV prevention, care and treatment in an era of shifting immigration policy and discourse

Changes in the United States federal-level political landscape have been felt within immigrant communities, and the public health clinics that serve them. We sought to document how HIV prevention and care clinics in California are reaching and retaining their immigrant community patients during a period of retrenchment of accessible public resources and immigrant rights. Paper available at: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0229291

Join our Mailing List:

Send this to a friend